Galera Therapeutics (GRTX) Is Rocketing On Positive Clinical Results

Galera Therapeutics GRTX Stock News

Galera Therapeutics Inc (NASDAQ: GRTX) is rocketing in the market this morning after announcing updated results from a trial of GC4419 in patients with advanced pancreatic cancer. Here’s what’s going on: Galera Therapeutics Announced Positive Clinical Results In a press release, Galera Therapeutics let investors in on new data from a Phase ½ pilot trial … Read more